There are now many molecular biological techniques available to define
HLA class I and class II alleles. Some of these are also applicable t
o other human polymorphic genes, in particular to those non-HLA genes
encoded within the Mhc. The range of techniques available allows labor
atories to choose those most suited to their purpose. The routine labo
ratory supporting solid organ transplants will need to type large numb
ers of potential recipients over a period of time, probably using PCR-
SSOP while donors will be typed singly and rapidly using PCR-SSP with
HLA allele compatibility determined by heteroduplex analysis. Laborato
ries supporting bone marrow transplantation, where time is less pressi
ng, can choose from the whole range of techniques to determine accurat
ely donor recipient Mhc compatibility. For disease studies, techniques
defining precise HLA allele sequence polymorphisms are needed and hig
h sample numbers have to be accommodated. When an association is estab
lished allele sequencing has to be used. In the near future, the preci
se role of HLA alleles in transplantation and disease susceptibility i
s likely to be established unambiguously.